Chief Operating Officer

Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half

Adaptimmune Reports Q2 Financial Results and Provides Business Update

US WorldMeds acquires Adaptimmune cell-therapy for $55M

US WorldMeds Completes Acquisition of Adaptimmune's Cell-Therapy Portfolio; Ensures Continued Patient Access to Tecelra and Advances Development of lete-cel

Director, Regulatory Affairs

US WorldMeds is a company focused on the development and execution of global regulatory strategies. The Director of Global Regulatory Affairs CMC will lead the development and filing strategies for CMC modules, providing regulatory guidance to cross-functional teams and ensuring compliance with global regulatory requirements.

Sign up with Google

Sign in with Google